abagovomab 8
abciximab 21
abituzumab 10
abrilumab 12
actoxumab 8
adalimumab 9
aducanumab 5
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 18
alirocumab 7
amatuximab 14
andecaliximab 9
anifrolumab 11
anrukinzumab 10
aprutumab 6
aprutumab_ixadotin 6
arcitumomab 9
ascrinvacumab 0
atezolizumab 10
atinumab 10
avelumab 7
basiliximab 13
bavituximab 11
begelomab 11
benralizumab 9
bevacizumab_beta 10
bezlotoxumab 8
bimagrumab 8
bleselumab 5
blinatumomab 16
blosozumab 22
bococizumab 14
brazikumab 7
brentuximab_vedotin 13
briakinumab 6
brodalumab 7
brolucizumab 14
brontictuzumab 14
burosumab 12
cabiralizumab 7
camrelizumab 4
canakinumab 12
cantuzumab_ravtansin 22
carlumab 11
carotuximab 8
cergutuzumab_amunaleukin2 23
cergutuzumab_amunaleukin 23
certolizumab_pegol 16
cetiximab 23
citatuzumab_bogatox 21
cixutumumab 12
clivatuzumab_tetraxetan 10
codrituzumab 18
conatumumab 8
concizumab 14
crenezumab 9
crizanlizumab 14
crotedumab 16
dacetuzumab 20
daclizumab 5
dalotuzumab 17
dapirolizumab_pegol 16
daratumumab 10
dectrekumab 3
demcizumab 15
denosumab 7
depatuxizumab 11
depatuxizumab_mafodotin 11
dezamizumab 3
dinutuximab 21
diridavumab 4
domagrozumab 5
drozitumab 7
duligotuzumab 19
durvalumab 5
dusigitumab 5
efalizumab 25
efungumab 14
eldelumab 6
elezanumab 10
elgemtumab 3
elotuzumab 9
emactuzumab 12
emapalumab 11
emibetuzumab 8
enavatuzumab 19
enfortumab_vedotin 6
enoblituzumab 12
enokizumab 15
enoticumab 9
ensituximab 10
eptinezumab 9
erenumab 7
etaracizumab 12
etrolizumab 18
evinacumab 13
evolocumab 3
farletuzumab 0
fasinumab 13
fezakinumab 9
fibatuzumab 0
ficlatuzumab 13
firivumab 19
flanvotumab 5
fletikumab 14
foralumab 4
foravirumab 11
fremanezumab 16
fresolimumab 10
fulranumab 13
futuximab 10
galcanezumab 10
ganitumab 14
gantenerumab 3
gemetuzumab 15
gemtuzumab2 18
gemtuzumab 8
gevokizumab 15
girentuximab 16
glembatumumab 13
glembatumumab_vedotin 13
guselkumab 14
ibalizumab 11
ibritumomab 10
icrucumab 7
idarucizumab 18
ifabotuzumab 0
imalumab 11
imgatuzumab 10
inclacumab 10
indatuximab_ravtansin 18
indusatumab 6
inebilizumab 13
intetumumab 3
iodine_girentuximab 18
ipilimumab 0
iratumumab 4
isatuximab 13
itolizumab 15
ixekizumab 14
labetuzumab_govitecan 15
lambrolizumab 11
lampalizumab 17
lanadelumab 15
landogrozumab 12
laprituximab 16
lebrikizumab 18
lendalizumab 19
lenzilumab 6
lifastuzumab_vedotin 15
ligelizumab 7
lilotomab 15
lirilumab 11
lodelcizumab 12
lokivetmab 11
lorvotuzumab_mertansin 7
lucatumumab 19
lumretuzumab 9
lupartumab 8
lutikizumab 9
margetuximab 21
milatuzumab 17
mirvetuximab 18
mirvetuximab_soravtansin 18
modotuximab 22
mogamulizumab 17
monalizumab 12
motavizumab 19
moxetumomab_pasudotox 14
namilumab 12
naratuximab 13
naratuximab_emtansin 13
narnatumab 8
navicixizumab2 19
navicixizumab 15
navivumab 11
necitumumab 3
nemolizumab 13
nesvacumab 11
nivolumab 7
obiltoxaximab 12
obinutuzumab 22
ocaratuzumab 12
ofatumumab 9
olaratumab 8
olokizumab 19
omalizumab 15
onartuzumab 16
ontuxizumab 8
opicinumab 13
orticumab 6
otelixizumab 18
oxelumab 7
ozanezumab 14
pamrevlumab 6
panobacumab 16
parsatuzumab 19
pasotuxizumab 16
pateclizumab 9
patritumab 9
pembrolizumab 11
perakizumab 15
pidilizumab 11
pinatuzumab_vedotin 11
plozalizumab 13
pogalizumab 9
polatuzumab_vedotin 17
ponezumab 17
prezalumab 11
pritoxaximab 19
quilizumab 11
racotumomab 16
radretumab 7
ralpancizumab 19
ramucirumab 7
ranevetmab 22
ranibizumab 7
refanezumab 14
remtolumab 10
rilotumumab 6
rinucumab 3
risankizumab 20
rituximab 3
rivabazumab 12
robatumumab 18
roledumab 9
romosozumab 10
rontalizumab 13
rosmantuzumab 10
rozanolixizumab 11
sacituzumab 17
sacituzumab_govitecan 17
samalizumab 14
sapelizumab 13
sarilumab 6
secukinumab 6
seribantumab 13
setoxaximab 23
sifalimumab 3
siltuximab 7
simtuzumab 14
sirukumab 8
solanezumab 21
solitomab 9
stamulumab 11
suptavumab 17
suvizumab 8
tabalumab 0
tadocizumab 4
tamtuvetmab 21
tanezumab 13
tarextumab 5
tavolixizumab 8
telisotuzumab 18
teplizumab 8
tesidolumab 10
tezepelumab 12
tigatuzumab 12
tildrakizumab 11
timolumab 6
tisotumab 5
tosatoxumab 17
tositumomab 10
tralokinumab 16
trastuzumab 19
tregalizumab 17
trevogrumab 7
ublituximab 12
urelumab 9
ustekinumab 19
utomilumab 16
vadastuximab 11
vadastuximab_talirin 11
vandortuzumab_vedotin 8
vantictumab 11
vanucizumab2 10
vanucizumab 8
varlilumab 13
vatelizumab 8
vedolizumab 6
veltuzumab 0
vesencumab 4
vorsetuzumab 17
vorsetuzumab_mafodotin 17
vunakizumab 18
xentuzumab 12
zatuximab 22
